Bladder Cancer

Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study. February 7, 2025

Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer. February 7, 2025

Development of point-of-care tests for urinary bladder cancer - an historic review and view to future prospectives. February 6, 2025

Impact of late effects after treatment for bladder cancer with radical cystectomy on Quality of life: a case-control study. February 6, 2025

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy. February 5, 2025

Genome-wide association study and Mendelian randomization analyses reveal insights into bladder cancer etiology. February 5, 2025

Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC). February 4, 2025

Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis. February 4, 2025

Unusual Presentation of Advanced Urothelial Cancer in a Young Patient. February 4, 2025

Current and Future Role of Circulating DNA in the Diagnosis and Management of Urothelial Carcinoma. February 3, 2025

Prospective comparative study of quality of life in patients with bladder cancer undergoing cystectomy with ileal conduit or bladder preservation. February 3, 2025

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma. January 31, 2025

A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder Cancer. January 31, 2025

The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data. January 30, 2025

The Global RAdical Cystectomy Evaluation and Management (GRACEM) pathway: single-centre prospective observational cohort study protocol. January 30, 2025

A novel bladder cancer surveillance schedule using bladder Cx for patients on annual surveillance. January 30, 2025

Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma January 29, 2025

Evaluation of the association between lymph node ratio and long-term survival in patients after surgery for lymph node-positive bladder cancer: a SEER population-based study with external validation. January 29, 2025

Predictive value of Bladder EpiCheck® in detecting residual tumor before second TUR for non-muscle-invasive bladder cancer. January 29, 2025

ImmunityBio Announces European Medicines Agency Acceptance of Marketing Authorization Application for ANKTIVA® for the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ January 28, 2025

Page 1 of 527